[144] MetLife, Inc. SEC Filing

Rhea-AI Filing Summary

MetLife, Inc. (MET) – Form 144 filing: The notice discloses a proposed sale of 101 common shares with an aggregate market value of $7,933.55. The shares were originally purchased on 12/17/2019 for cash and are slated to be sold through Barclays Capital on or about 06/20/2025 on the NYSE. The issuer has 671,297,826 shares outstanding, so the planned transaction represents less than 0.00002 % of equity. The filing also lists earlier sales by related MetLife accounts over the past three months totaling 686 shares for gross proceeds of $55,391.75. The signer affirms no undisclosed material adverse information and Rule 144 compliance.

Insights

Financial Analyst

TL;DR: Tiny Rule 144 sale (101 MET shares) is immaterial; no valuation impact expected.

The Form 144 indicates a routine disposition of 101 MetLife common shares worth roughly $8 thousand. With over 671 million shares outstanding and daily trading volumes in the millions, the sale is statistically negligible and should not influence price discovery or liquidity. The disclosure nonetheless fulfills regulatory transparency, signalling no hidden adverse information per the filer’s representation.

Corporate Governance Expert

TL;DR: Compliance-only filing; confirms insider awareness of disclosure duties.

Form 144 requires insiders to pre-notify the market of intended sales above de-minimis thresholds. Although the share count is trivial, the filing demonstrates adherence to governance protocols and Rule 10b5-1 safe-harbour language. No red flags are evident, and the aggregate sales history disclosed remains modest, supporting a neutral governance assessment.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Barclays Capital 745 Seventh Ave New York NY 10019	101	7933.55	671297826	06/20/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	12/17/2019	Purchase	Bank of America			101	12/19/2019	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MetLife 401k Plan Trust-Large Cap Equity Index 1 Metlife Way Whippany NJ 07981	Common Stock	03/21/2025	335	27590.6
Separate Account SPI 1 Metlife Way Whippany NJ 07981	Common Stock	03/21/2025	77	6341.72
Separate Account II 1 Metlife Way Whippany NJ 07981	Common Stock	03/21/2025	47	3870.92
Separate Account 149 1 Metlife Way Whippany NJ 07981	Common Stock	03/21/2025	6	494.16
Separate Account II 1 Metlife Way Whippany NJ 07981	Common Stock	06/13/2025	221	17094.35

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many MetLife (MET) shares are proposed for sale under this Form 144?

The filer intends to sell 101 common shares of MetLife.

What is the estimated market value of the shares being sold?

The aggregate market value is $7,933.55 according to the notice.

When is the approximate sale date for the MET shares?

The filing lists an approximate sale date of 06/20/2025.

How many MetLife shares are outstanding compared with the amount being sold?

MetLife has 671,297,826 shares outstanding; the proposed 101-share sale equals about 0.00002 % of total shares.

Which broker will handle the transaction?

The shares are to be sold through Barclays Capital, 745 Seventh Ave, New York NY 10019.